Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Study of Diagnostic Efficiency of 68Ga-PSMA PET in the Patients With Locally Advanced and Advanced Renal Cell Carcinoma

NCT04987086 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04987086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04987086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Study of Diagnostic Efficiency of 68Ga-PSMA PET in the Patients With Locally Advanced and Advanced Renal Cell Carcinoma
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2021
Completion date
December 1, 2027
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

metastases, psma pet, renal cancer